Why VKTX? Viking Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
VKTX
$30.00-1.18 (-3.78%)
Market ClosedLast close May 1
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.